Multi-dimensional monitoring of cognition and cerebellar function to prospectively define disease progression in multiple sclerosis [ 1/1/2021 - 12/31/2025 ]

Research Grant

Brief description Multiple Sclerosis (MS) is an autoimmune degenerative brain disease that cost Australia >$1.7 billion/year in lost productivity. An estimated 50% of people with MS (pwMS) develop unrelenting, progressive disability (secondary progressive MS, SPMS). SPMS is currently diagnosed retrospectively by observing inexorable worsening in neurological function without relapses for > 6 month

Funding Amount $1,462,250

Funding Scheme Investigator Grants

Chief Investigator A/Pr Anneke van der Walt

Notes Emerging Leadership 2